Search

Your search keyword '"Murugan, S."' showing total 1,626 results
Start Over Author "Murugan, S."
1,626 results on '"Murugan, S."'

25. Finite Element Modelling and Dynamic Stability Analysis of a Functionally Graded Rotor Shaft-Bearing System

Author

Bala Murugan, S., Behera, R. K., Ceccarelli, Marco, Series Editor, Agrawal, Sunil K., Advisory Editor, Corves, Burkhard, Advisory Editor, Glazunov, Victor, Advisory Editor, Hernández, Alfonso, Advisory Editor, Huang, Tian, Advisory Editor, Jauregui Correa, Juan Carlos, Advisory Editor, Takeda, Yukio, Advisory Editor, Tiwari, Rajiv, editor, Ram Mohan, Y. S., editor, Darpe, Ashish K., editor, Kumar, V. Arun, editor, and Tiwari, Mayank, editor

Published
2024
Full Text
View/download PDF

27. Energetic and Exergetic Performance of an Evacuated Tube U-Type Solar Collector for Medium-Temperature Industrial Process Air Heating: An Experimental Study

Author

Bhaskara Rao, Thota S. S., Murugan, S., Chaari, Fakher, Series Editor, Gherardini, Francesco, Series Editor, Ivanov, Vitalii, Series Editor, Haddar, Mohamed, Series Editor, Cavas-Martínez, Francisco, Editorial Board Member, di Mare, Francesca, Editorial Board Member, Kwon, Young W., Editorial Board Member, Trojanowska, Justyna, Editorial Board Member, Xu, Jinyang, Editorial Board Member, Singh, Krishna Mohan, editor, Dutta, Sushanta, editor, Subudhi, Sudhakar, editor, and Singh, Nikhil Kumar, editor

Published
2024
Full Text
View/download PDF

38. A cross sectional study of dietary practices and nutritional status of tuberculosis patients

Author

K Sathish Kumar, Aby Thomas, Arun Murugan S, Ramasubramanian R, Aravind G, and K Sathishkumar

Subjects
dietary practices, nutrition, tuberculosis patients, Medicine
Abstract

Introduction: Tuberculosis (TB) is caused by Mycobacterium tuberculosis which often affect the lungs, although it can spread to other organs in the body. TB is the second deadliest disease worldwide caused by a single infectious agent Objective: evaluate the nutritional status of active TB patients in a tertiary care medical college hospital in Chennai. Methods: This was a descriptive cross-sectional study conducted from August 2022-September 2022 among active Tuberculosis patients in a tertiary care medical college hospital in Chennai who had tested positive by sputum microscopy and are under treatment. Sample size was calculated to be 105. Participants were selected by simple random sampling. Sampling was done by simple random sampling of the study population. Data on clinical and demographic characteristics and dietary intake was collected using questionnaire. Results: Mean age of the participants was 34, 04 years. The energy intake of most (62, 9 %) of the participants was found to be less than the RDA levels for Tuberculosis patients. Inadequate calorie consumption was found to be significantly associated with the presence of complications of tuberculosis after adjusting for age and gender with an odds ratio of 3, 24 (95 % CI, 1, 45-6, 74). Conclusion: Inadequate calorie intake was significantly associated with presence of complications of tuberculosis. Proper nutritional counseling along with nutritional support should be given to severely malnourished TB patients, and nutritional assessment of TB patients should be done periodically.

Published
2024

47. A Novel Design of Ultra-wideband Microstrip Antenna for Microwave Imaging Application

Author

Jeyashree, N., Jothi, M. Jeya, Dhanalakshmi, K. Mala, Karuppasamy, P., Murugan, S., Kacprzyk, Janusz, Series Editor, Pal, Nikhil R., Advisory Editor, Bello Perez, Rafael, Advisory Editor, Corchado, Emilio S., Advisory Editor, Hagras, Hani, Advisory Editor, Kóczy, László T., Advisory Editor, Kreinovich, Vladik, Advisory Editor, Lin, Chin-Teng, Advisory Editor, Lu, Jie, Advisory Editor, Melin, Patricia, Advisory Editor, Nedjah, Nadia, Advisory Editor, Nguyen, Ngoc Thanh, Advisory Editor, Wang, Jun, Advisory Editor, Ranganathan, G., editor, EL Allioui, Youssouf, editor, and Piramuthu, Selwyn, editor

Published
2023
Full Text
View/download PDF

50. Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis

Author

Kelly, Nicole K, Chattopadhyay, Aheli, Rathinam, SR, Gonzales, John A, Thundikandy, Radhika, Kanakath, Anuradha, Murugan, S Bala, Vedhanayaki, R, Cugley, Dean, Lim, Lyndell L, Suhler, Eric B, Al-Dhibi, Hassan A, Ebert, Caleb D, Berlinberg, Elyse J, Porco, Travis C, Acharya, Nisha R, Subramanian, AL Sivarama, Jeyakohila, G, Evangelin, Gracy, Azhagupandi, AM, Praba, CV, Bharati, S, Gomathi, S, Nirmaladevi, NJ, Siddiq, Mohammed, Vijayakumar, B, Devi, SR, Saravanan, VR, Babu, Upendra, Srija, R, Dhanalakshmi, S, Sakthimari, RR, Keerthana, PS, Mallika, AM, Vasanthi, C, Mariselvi, PB, Pandeeswari, P, Sudarvanitha, SM, Prema, R, Baskaran, Prabu, Madanagopalan, S, Nagesha, Chokkahalli K, Thilagavathi, R, Krishnakumari, Chitra, P, Irudhaya Raj, Saravanan, S, Mary, Grace, Nagarasi, S, Gnansi, Kiruba, Arellanes-Garcia, Lourdes, del Rio, Luz Elena Concha, Kalb, Rashel Cheja, Fernández, Nancy, Burgoa, Yoko, Hernández, Hilda, Cuello, Roberto Fabela, Garcia, Lorenzo Agustín Martínez, Rodríguez, Ricardo Montoya, del Carmen Preciado, Maria, Arreola, Andrea, Stone, Donald, Al-Shamrani, Mohammed, Al-Nuwaysir, Sara, Al-Hommadi, Abdulrahman, Al-Omran, Abdullah, Al-Nasser, Saleh, Al-Zahrani, Gahram, Mashan, Eman, Al-Ghamdi, Mizher, Al-Tuwejri, Ayshah, Goldstein, Debra A, Castro-Malek, Anna Liza, Dela Rosa, Gemma, Skelly, Marriner, Suhler, Eric, Rosenbaum, James, Lin, Phoebe, Salek, Sherveen, Biggee, Kristin, Shifera, Amde, Kopplin, Laura, Mount, George, Giles, Tracy, Nolte, Susan, Lundquist, Ann, Liesegang, Teresa, Romo, Albert, Howell, Chris, Pickell, Scott, Steinkemp, Peter, Ryan, Dawn, Barth, Jordan, Hui, Jocelyn, and Ukachukwu, Chiedozie

Subjects
Biomedical and Clinical Sciences, Ophthalmology and Optometry, Clinical Research, Eye Disease and Disorders of Vision, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, Administration, Oral, Adult, Aged, Enzyme Inhibitors, Female, Health, Health Status, Humans, Immunosuppressive Agents, Male, Methotrexate, Middle Aged, Mycophenolic Acid, Prospective Studies, Quality of Life, Sickness Impact Profile, Surveys and Questionnaires, Uveitis, Vision, Ocular, Antimetabolites, uveitis, Quality of life, FAST Research Group, Clinical Sciences, Opthalmology and Optometry, Public Health and Health Services, Ophthalmology & Optometry, Ophthalmology and optometry
Abstract

PurposeTo evaluate changes in health-related and vision-related quality of life (VRQoL) among patients with noninfectious uveitis who were treated with antimetabolites.DesignSecondary analysis of a randomized controlled trial.ParticipantsPatients with noninfectious uveitis from India, the United States, Australia, Saudi Arabia, and Mexico.MethodsFrom 2013 through 2017, 216 participants were randomized to receive 25 mg weekly oral methotrexate or 1.5 g twice daily oral mycophenolate mofetil. Median changes in quality of life (QoL) were measured using Wilcoxon signed-rank tests, and differences between treatment groups were measured using linear mixed models, adjusting for baseline QoL score, age, gender, and site. Among Indian patients, VRQoL scores from a general scale (the National Eye Institute Visual Function Questionnaire [NEI-VFQ]) and a culturally specific scale (the Indian Visual Function Questionnaire [IND-VFQ]) were compared using Pearson correlation tests.Main outcome measuresVision-related QoL (NEI-VFQ and IND-VFQ) and health-related QoL (HRQoL; physical component score [PCS] and mental component score [MCS] of the Medical Outcomes Study 36-Item Short Form Survey [SF-36v2]) were measured at baseline, the primary end point (6 months or treatment failure before 6 months), and the secondary end point (12 months or treatment failure between 6 and 12 months).ResultsAmong 193 participants who reached the primary end point, VRQoL increased from baseline by a median of 12.0 points (interquartile range [IQR], 1.0-26.1, NEI-VFQ scale), physical HRQoL increased by a median of 3.6 points (IQR, -1.4 to 14.9, PCS SF-36v2), and mental HRQoL increased by a median of 3.0 points (IQR, -3.7 to 11.9, MCS SF-36v2). These improvements in NEI-VFQ, SF-36v2 PCS, and SF-36v2 MCS scores all were significant (P < 0.01). The linear mixed models showed that QoL did not differ between treatment groups for each QoL assessment (NEI-VFQ, IND-VFQ, PCS SF-36v2, and MCS SF-36v2; P > 0.05 for all). The NEI-VFQ and IND-VFQ scores for Indian participants were correlated highly at baseline and the primary and secondary end points (correlation coefficients, 0.87, 0.80, and 0.90, respectively).ConclusionsAmong patients treated with methotrexate or mycophenolate mofetil for uveitis, VRQoL and HRQoL improved significantly over the course of 1 year and did not differ by treatment allocation. These findings suggest that antimetabolites could improve overall patient well-being and daily functioning.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results